MDXG News and Press, MiMedx Group Inc From 08/12/21

Promotion Recognizes Skilled Leadership and Contributions to MIMEDX’s Continued Growth MARIETTA, Ga., Aug. 12, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a ...

MiMedx Group, Inc. (MDXG) Q2 2021 Earnings Conference Call August 04, 2021, 08:30 AM ET Company Participants Jack Howarth - SVP of IR Tim Wright - CEO Pete Carlson - CFO Robert Stein - EVP of R&D Rohit Kashyap - EVP and CCO Conference Call Participants Carl Byrnes - Northland Securities J...

Second Quarter Net Sales Increase 27% to $68.2 million Versus Q2 2020 On Track to Deliver Topline Results for Late-Stage Musculoskeletal Pipeline in Late Summer Company to Host Conference Call on August 4, 2021, at 8:30 AM ET MARIETTA, Ga., Aug. 03, 2021 (GLOBE NEW...

Sold out of the China uncertainty as I await a potential major flushing in those stocks if China decides to make an example out of a company like DiDi. A hit to Arrowhead Pharmaceuticals presented a buying opportunity while Bitcoin shows signs of wanting to break out. A portfolio ...

MARIETTA, Ga., July 20, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that it will report operating and financial re...

MIMEDX Applauds Dr. Laurencin on Receiving NAACP’s Highest Honor for His Contributions to Emerging Medical Sciences that Advance Human Healing MARIETTA, Ga., July 14, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company&#...

Massive trade on a binary event makes my month and helps eliminate much of my underperformance so far this year. Big buys on a couple of new stocks in June set my portfolio up for success as I consolidate my stocks down to more concentrated bets. A portfolio built for individual i...

MiMedx Group (MDXG) will join the Russell 3000 and Russell 2000 Indexes following the 2021 Russell indexes reconstitution, effective June 28 after the U.S. market opens. "This significant achievement is indicative of our continued progress in restoring the MIMEDX name and positive outloo...

MARIETTA, Ga., June 28, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today confirmed that FTSE Russell will add the Company’...

MARIETTA, Ga, June 16, 2021 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) (“MIMEDX” or the “Company”), an industry leader in utilizing amniotic tissue as a platform for regenerative medicine, today announced that Timothy R. Wright, Chief Executive Of...